Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-05-08
DOI
10.1002/jcsm.12438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy
- (2018) Gonzalo Cordova et al. Frontiers in Genetics
- Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice
- (2017) Jennifer A Tinklenberg et al. HUMAN MOLECULAR GENETICS
- Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology
- (2017) Katherine E. Vest et al. HUMAN MOLECULAR GENETICS
- Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes
- (2017) Jerry R. Mendell et al. MOLECULAR THERAPY
- Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing
- (2017) Ayan Banerjee et al. NUCLEIC ACIDS RESEARCH
- PABPN1 gene therapy for oculopharyngeal muscular dystrophy
- (2017) A. Malerba et al. Nature Communications
- Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017
- (2017) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys
- (2017) Michael St. Andre et al. Skeletal Muscle
- Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial
- (2016) Craig Campbell et al. MUSCLE & NERVE
- A decline in PABPN1 induces progressive muscle weakness in Oculopharyngeal muscle dystrophy and in muscle aging
- (2016) Seyed Yahya Anvar et al. Aging-US
- Progress on Gene Therapy, Cell Therapy, and Pharmacological Strategies Toward the Treatment of Oculopharyngeal Muscular Dystrophy
- (2015) Pradeep Harish et al. HUMAN GENE THERAPY
- Poly(A) Polymerase and the Nuclear Poly(A) Binding Protein, PABPN1, Coordinate the Splicing and Degradation of a Subset of Human Pre-mRNAs
- (2015) Lisa Muniz et al. MOLECULAR AND CELLULAR BIOLOGY
- Regulated Intron Retention and Nuclear Pre-mRNA Decay Contribute toPABPN1Autoregulation
- (2015) Danny Bergeron et al. MOLECULAR AND CELLULAR BIOLOGY
- A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
- (2015) Jerry R Mendell et al. MOLECULAR THERAPY
- Autologous Myoblast Transplantation for Oculopharyngeal Muscular Dystrophy: a Phase I/Iia Clinical Study
- (2013) Sophie Périé et al. MOLECULAR THERAPY
- BMP signaling controls muscle mass
- (2013) Roberta Sartori et al. NATURE GENETICS
- The Human Nuclear Poly(A)-Binding Protein Promotes RNA Hyperadenylation and Decay
- (2013) Stefan M. Bresson et al. PLoS Genetics
- Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle
- (2013) Luciano H Apponi et al. Skeletal Muscle
- The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation Sites
- (2012) Mathias Jenal et al. CELL
- Inhibition of myostatin reverses muscle fibrosis through apoptosis
- (2012) Zhao Bo Li et al. JOURNAL OF CELL SCIENCE
- Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation
- (2012) Eleonora de Klerk et al. NUCLEIC ACIDS RESEARCH
- Polyadenylation-Dependent Control of Long Noncoding RNA Expression by the Poly(A)-Binding Protein Nuclear 1
- (2012) Yves B. Beaulieu et al. PLoS Genetics
- Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
- (2011) Liping Zhang et al. FASEB JOURNAL
- Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy
- (2011) Janet E. Davies et al. HUMAN MOLECULAR GENETICS
- Fiber Types in Mammalian Skeletal Muscles
- (2011) Stefano Schiaffino et al. PHYSIOLOGICAL REVIEWS
- Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients
- (2011) Seyed Anvar et al. Skeletal Muscle
- Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres
- (2010) Capucine Trollet et al. HUMAN MOLECULAR GENETICS
- Crossing the borders: Poly(A)-binding proteins working on both sides of the fence
- (2010) Jean-François Lemay et al. RNA Biology
- Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia
- (2009) Margaret E. Benny Klimek et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis
- (2009) Luciano H. Apponi et al. HUMAN MOLECULAR GENETICS
- A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
- (2008) Kathryn R. Wagner et al. ANNALS OF NEUROLOGY
- Recombinant Antibodies as Therapeutic Agents
- (2008) Frederico Aires da Silva et al. BIODRUGS
- Clinical, Agricultural, and Evolutionary Biology of Myostatin: A Comparative Review
- (2008) Buel D. Rodgers et al. ENDOCRINE REVIEWS
- Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation
- (2008) Janet E. Davies et al. HUMAN MOLECULAR GENETICS
- Myostatin Directly Regulates Skeletal Muscle Fibrosis
- (2008) Zhao Bo Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started